Chemotherapy Drugs Causing Constipation
The primary chemotherapy drugs that cause constipation in adult oncology patients are vinca alkaloids (especially vincristine), with 5-HT3 receptor antagonist antiemetics and thalidomide also being significant contributors. 1
Specific Chemotherapy Agents
Vinca Alkaloids - Highest Risk
All vinca alkaloids cause pronounced constipation through neuropathic effects that prolong gastrointestinal transit time. The severity hierarchy is:
- Vincristine: Most severe, dose-related effects particularly at total doses >2 mg
- Vindesine: Severe effects
- Vinblastine: Moderate effects
- Vinorelbine: Least severe among vinca alkaloids 1
5-HT3 Receptor Antagonist Antiemetics
These agents (ondansetron, granisetron, palonosetron) slow colonic transit, increase fluid absorption, and increase left colon compliance. Laxative therapy is often indicated when these antiemetics are used 1. This is particularly relevant since these drugs are routinely given with highly emetogenic chemotherapy regimens like cisplatin-containing treatments 2.
Thalidomide
Constipation is the most common adverse event of thalidomide after sedation 1.
Platinum-Based Chemotherapy Context
While cisplatin itself is not directly listed as constipating, cisplatin-containing regimens have high rates of chemotherapy-induced constipation (82.5% grade ≥2 constipation) partly because of the concomitant use of neurokinin-1 and 5-HT3 receptor antagonists required for nausea control 2.
CHOP Regimen
In patients receiving CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) or CHOP-like regimens, the vincristine component drives constipation risk, making prophylactic laxative management critical to prevent paralytic ileus 3.
Critical Clinical Pitfalls
The ESMO guidelines emphasize that constipation in cancer patients is often poorly recognized and poorly treated despite causing major morbidity and distress 1. The prevalence ranges from 40-90% in advanced cancer patients 1.
Important Drug Interactions
When managing vincristine-induced or other chemotherapy-related constipation, avoid combining magnesium oxide with proton pump inhibitors or H2 receptor antagonists, as antacids reverse the laxative action of magnesium oxide 3. This is particularly problematic since 99% of patients on CHOP regimens receive anti-ulcer agents for prednisolone-related gastric protection 3.
Beyond Chemotherapy Agents
While not chemotherapy per se, opioid analgesics used for cancer pain are the most common medication cause of constipation in oncology patients. All opioids cause constipation without development of tolerance, and the dose-response relationship is relatively flat 1.